Form 4 Tracker
Johanna Friedl-Naderer

Chief Commercial Officer · 3 filings · Latest: May 13, 2026

Dyne Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
DYN
Johanna Friedl-NadererChief Commercial OfficerMay 13, 2026
Sale
$18.36228$4.2K154,353
DYN
Johanna Friedl-NadererChief Commercial OfficerMar 5, 2026
Sale
$14.90148$2.2K154,581
Johanna Friedl-Naderer — Insider Trading Activity | LevelFields AI